tirzepatide safety breastfeeding Shed If you're on a GLP-1

In diabetic ED models, a transcriptomic analysis demonstrated downregulation of genes involved in smooth muscle contractility and mitochondrial function, alongside upregulation of Wnt signaling and extracellular matrix remodeling [183]

HOWEVER, PATIENTS CAN STOP DOSAGE INCREASES IF THEY ARE ACHIEVING IDEAL RESULTS AT ANY DOSE AND USE THAT AS THEIR MAINTENAINCE DOSE

The FDA has published broader guidance on compounded GLP-1 products worth knowing regardless of which telehealth platform you're considering

Abstract Background: Despite advancements in care, many people with type 2 diabetes do not meet treatment goals

Availability and Cost

Both tirzepatide and retatrutide produce gastrointestinal side effects as their primary adverse reactions, but the frequency, severity, and specific patterns differ between the two compounds